Common Gastrointestinal Concerns Both dual and triple agonists share a class-wide side effect profile dominated by gastrointestinal issues, primarily: Nausea Diarrhea or Constipation Vomiting These effects are dose-related and typically peak during the dose-escalation phase
The insulinotropic effects of GLP-1, and the reduction of its effects in type 2 diabetes mellitus (T2DM), have made GLP-1 an attractive option for the treatment of T2DM
Instead, Lemme GLP-1 Daily takes a different approach, using three clinically-studied ingredients that may help support the body's natural hormone production and appetite signaling pathways
Some people transition to lower maintenance doses after reaching goals, while others continue their effective dose indefinitely under medical supervision.
When administered, they slow gastric emptying, reduce hunger signals, and help patients feel satisfied with smaller portions of food